Abstract
Neuropathic pain (NP) is commonly associated with mitochondrial dysfunction in sensory neurons. Although resveratrol (Res), a natural polyphenolic compound, has demonstrated analgesic properties, its impact on mitochondrial dynamics in NP remains unclear. We established a chronic constriction injury (CCI) model in male mice. Starting on the seventh day after the injury, resveratrol (1 mg/kg) or vehicle was administered via intrathecal injection for three consecutive days. We evaluated pain behaviors and analyzed dorsal root ganglia (DRG) for markers of oxidative stress, mitochondrial respiratory chain complexes, fission (DRP1) and fusion (OPA1) proteins, and mitochondrial morphology/ultrastructure. Resveratrol significantly reduced CCI-induced mechanical hypersensitivity and restored thermal latency. In DRG, reactive oxygen species (ROS) accumulation decreased, while superoxide dismutase (SOD) activity increased, indicating reduced oxidative stress. Mitochondrial respiratory chain complexes I–II were restored, while DRP1 expression decreased and OPA1 increased, suggesting a normalization of fission–fusion balance. Resveratrol also increased mitochondrial volume and number. Ultrastructural deficits in mitochondrial area, perimeter, and connectivity were reversed. Resveratrol mitigates CCI-induced NP associated with restoring the balance of mitochondrial fission and fusion proteins and reducing oxidative stress in DRG. These results provide credence to the idea of mitochondrial dynamics as a potential NP target. However, this study did not establish a causal relationship between these molecular changes and resveratrol’s analgesic effects through direct manipulation of proteins. Further validation is needed through experiments targeting key proteins involved in mitochondrial fission and fusion.
Data availability
The data underlying the findings of this study are available from the corresponding author upon reasonable request.
References
Finnerup, N. B., Kuner, R. & Jensen, T. S. Neuropathic pain: From mechanisms to treatment. Physiol. Rev. 101(1), 259–301 (2021).
Cheng, X. et al. Mitochondria-targeting bimetallic cluster nanozymes alleviate neuropathic pain through scavenging ROS and reducing inflammation. Adv. Healthc. Mater. 14(8), e2401607 (2025).
Mandlem, V. K. K. et al. TLR4 induced TRPM2 mediated neuropathic pain. Front. Pharmacol. 15, 1472771 (2024).
Zhang, W. et al. Spinal AT1R contributes to neuroinflammation and neuropathic pain via NOX2-dependent redox signaling in microglia. Free Radic Biol. Med. 227, 143–156 (2025).
Xu, Z. et al. The role of antioxidant therapy in modulating neuropathic pain: A systematic review of mechanistic insights and research trends (2003–2024). Brain Circ. 11(2), 113–126 (2025).
Palma, F. R. et al. ROS production by mitochondria: Function or dysfunction?. Oncogene 43(5), 295–303 (2024).
Chan, D. C. Mitochondrial dynamics and its involvement in disease. Annu. Rev. Pathol. 15, 235–259 (2020).
Vasquez-Trincado, C. et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J. Physiol. 594(3), 509–25 (2016).
Palmeira, C. M. et al. Mitohormesis and metabolic health: The interplay between ROS, cAMP and sirtuins. Free Radic. Biol. Med. 141, 483–491 (2019).
Ma, Y., Wang, L. & Jia, R. The role of mitochondrial dynamics in human cancers. Am. J. Cancer Res. 10 (5), 1278–1293 (2020).
Pernas, L. & Scorrano, L. Mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function. Annu. Rev. Physiol. 78, 505–531 (2016).
Xie, L. et al. Mechanistic study of modulating mitochondrial fission and fusion to ameliorate neuropathic pain in mice. Sci. Rep. 15(1), 15571 (2025).
George, D. S. et al. Mitochondrial calcium uniporter deletion prevents painful diabetic neuropathy by restoring mitochondrial morphology and dynamics. Pain 163 (3), 560–578 (2022).
Doyle, T. M. & Salvemini, D. Mini-review: Mitochondrial dysfunction and chemotherapy-induced neuropathic pain. Neurosci. Lett. 760, 136087 (2021).
Xie, M. et al. 2-bromopalmitate attenuates inflammatory pain by maintaining mitochondrial fission/fusion balance and function. Acta Biochim. Biophys. Sin. (Shanghai) 53(1), 72–84 (2021).
Subhan, I. & Siddique, Y. H. Resveratrol: Protective agent against Alzheimer’s disease. Cent Nerv Syst Agents Med Chem 24(3), 249–263 (2024).
Lu, S. & Wang, X. The role and potential mechanism of resveratrol in the prevention and control of epilepsy. Future Med. Chem. 7 (15), 2005–2018 (2015).
Raj, P., Zieroth, S. & Netticadan, T. An overview of the efficacy of resveratrol in the management of ischemic heart disease. Ann. N. Y. Acad. Sci. 1348(1), 55–67 (2015).
Mu, Q. & Najafi, M. Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells. Int. Immunopharmacol. 98, 107895 (2021).
Kung, H. C. et al. Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson’s Disease. Biomedicines https://doi.org/10.3390/biomedicines9080918 (2021).
Zhou, J. et al. Beneficial effects of resveratrol-mediated inhibition of the mTOR pathway in spinal cord injury. Neural Plast. 2018, 7513748 (2018).
Meng, T. et al. Anti-inflammatory action and mechanisms of resveratrol. Molecules https://doi.org/10.3390/molecules26010229 (2021).
Salehi, B. et al. Resveratrol: A double-edged sword in health benefits. Biomedicines https://doi.org/10.3390/biomedicines6030091 (2018).
Dong, Z. B. et al. Resveratrol ameliorates oxaliplatin-induced neuropathic pain via anti-inflammatory effects in rats. Exp. Ther. Med. 24(3), 586 (2022).
Wang, B. et al. Deciphering resveratrol’s role in modulating pathological pain: From molecular mechanisms to clinical relevance. Phytother. Res. 38(1), 59–73 (2024).
Hernandez-Vazquez, L. et al. Anti-allodynic and anti-hyperalgesic activity of (+/-)-licarin A in neuropathic rats via NO-cyclic-GMP-ATP-sensitive K+ channel pathway. Drug Dev. Res. 85(1), e22134 (2024).
Bennett, G. J. & Xie, Y. K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1), 87–107 (1988).
Yin, Z. et al. ROS: Executioner of regulating cell death in spinal cord injury. Front. Immunol. 15, 1330678 (2024).
He, L. et al. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell. Physiol. Biochem. 44(2), 532–553 (2017).
Tian, Y. et al. Resveratrol as a natural regulator of autophagy for prevention and treatment of cancer. Onco Targets Ther 12, 8601–8609 (2019).
Wu, H. et al. Resveratrol: Harnessing nature’s potential for chronic pain relief. Aging Dis. (2025).
Inoue, H. & Nakata, R. Resveratrol targets in inflammation. Endocr. Metab. Immune Disord. Drug Targets 15(3), 186–195 (2015).
Singh, K., Gupta, J. K. & Kumar, S. The pharmacological potential of resveratrol in reducing soft tissue damage in osteoarthritis patients. Curr. Rheumatol. Rev. 20(1), 27–38 (2024).
Singh, A. P. et al. Health benefits of resveratrol: Evidence from clinical studies. Med. Res. Rev. 39(5), 1851–1891 (2019).
Sharma, S., Chopra, K. & Kulkarni, S. K. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: Participation of nitric oxide and TNF-alpha. Phytother. Res. 21(3), 278–83 (2007).
Wang, Y. et al. Resveratrol mediates mechanical allodynia through modulating inflammatory response via the TREM2-autophagy axis in SNI rat model. J. Neuroinflammation. 17 (1), 311 (2020).
Tao, L. et al. Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. Int. Immunopharmacol. 34, 165–172 (2016).
Yao, W. et al. Recombinant protein transduction domain-Cu/Zn superoxide dismutase alleviates bone cancer pain via peroxiredoxin 4 modulation and antioxidation. Biochem. Biophys. Res. Commun. 486(4), 1143–1148 (2017).
Recalde, M. D. et al. Resveratrol exerts anti-oxidant and anti-inflammatory actions and prevents oxaliplatin-induced mechanical and thermal allodynia. Brain Res. 1748, 147079 (2020).
Miguel, C. A. et al. Antioxidant, anti-inflammatory and neuroprotective actions of resveratrol after experimental nervous system insults. Special focus on the molecular mechanisms involved. Neurochem. Int. 150, 105188 (2021).
Singh, A. K. & Vinayak, M. Anti-nociceptive effect of resveratrol during inflammatory hyperalgesia via differential regulation of pro-inflammatory mediators. Phytother. Res. 30(7), 1164–71 (2016).
Nohl, H., Gille, L. & Staniek, K. Intracellular generation of reactive oxygen species by mitochondria. Biochem. Pharmacol. 69 (5), 719–723 (2005).
Islam, M. T. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol. Res. 39(1), 73–82 (2017).
Morato, L. et al. Mitochondrial dysfunction in central nervous system white matter disorders. Glia 62(11), 1878–94 (2014).
Zhang, H. et al. SIRT1 mediated inhibition of VEGF/VEGFR2 signaling by resveratrol and its relevance to choroidal neovascularization. Cytokine 76(2), 549–552 (2015).
Vercellino, I. & Sazanov, L. A. The assembly, regulation and function of the mitochondrial respiratory chain. Nat. Rev. Mol. Cell. Biol. 23 (2), 141–161 (2022).
Jheng, H. F. et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol. Cell. Biol. 32(2), 309–19 (2012).
Grel, H. et al. Mitochondrial dynamics in neurodegenerative diseases: Unraveling the role of fusion and fission processes. Int. J. Mol. Sci. https://doi.org/10.3390/ijms241713033 (2023).
Burte, F. et al. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11(1), 11–24 (2015).
Jin, H. W. et al. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: Effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp. Neurol. 210(1), 229–37 (2008).
Zhang, K. L. et al. Targeted up-regulation of Drp1 in dorsal horn attenuates neuropathic pain hypersensitivity by increasing mitochondrial fission. Redox Biol. 49, 102216 (2022).
Funding
This research was funded by the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 82203969), the Young and Middle-Aged Health Science and Technology Innovation Talent Training Program of the Henan Provincial Health Commission (Grant No. YQRC2024019), and the Clinical Medical Scientist Training Program of Henan Province (Grant No. HNCMS202433).
Author information
Authors and Affiliations
Contributions
Yanyan Sun designed the study and provided financial support. Liu Xie conducted behavioral tests, immunofluorescence experiments, Western blot analysis, and mitochondrial morphology assessments. Data analysis was carried out by Liu Xie, Wanting Chang, and Linna Song. The CCI model was developed by Liu Xie and Qingqing Yang. Liu Xie drafted the manuscript, which was revised by Yanyan Sun and Yiran Xu. All authors gave their approval for the final version of the manuscript.
Corresponding author
Ethics declarations
Consent for publication
All authors agree to take responsibility for their contributions and have approved the submitted version of this manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Xie, L., Xu, Y., Yang, Q. et al. Resveratrol alleviates neuropathic pain associated with restoration of mitochondrial fission–fusion balance in CCI mice. Sci Rep (2026). https://doi.org/10.1038/s41598-026-41965-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-41965-7
